|
|
TTD Drug ID:
DNC006813
Drug
Information |
Name | 1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C19H24N2O/c1-22-19-10-6-5-9-17(19)15-18(16-7-3-2-4-8-16)21-13- 11-20-12-14-21/h2-10,18,20H,11-15H2,1H3 | InChIKey | PFTJCYRHNKTTTO-UHFFFAOYSA-N | Canonical SMILES | COC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 | Target | Dopamine transporter |  | Inhibitor | [1] | Norepinephrine transporter |  | Inhibitor | [2] | Serotonin transporter |  | Inhibitor | [2] | Ref 1 | Bioorg Med Chem Lett. 2006 Aug 15;16(16):4345-8. Epub 2006 Jun 5.N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor. To Reference | Ref 2 | Bioorg Med Chem Lett. 2010 Jun 15;20(12):3788-92. Epub 2010 Apr 18.Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|